{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:09:57Z","timestamp":1791407397928,"version":"4.3.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T00:00:00Z","timestamp":1032134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1038\/nm764","type":"journal-article","created":{"date-parts":[[2002,9,30]],"date-time":"2002-09-30T15:44:22Z","timestamp":1033400662000},"page":"1129-1135","source":"Crossref","is-referenced-by-count":393,"title":["Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension"],"prefix":"10.1038","volume":"8","author":[{"given":"J.-M.","family":"Launay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Herv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Peoc'h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tournois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Callebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.G.","family":"Nebigil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Etienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Drouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Simonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Maroteaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,9,16]]},"reference":[{"key":"BFnm764_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0008-6363(97)00053-9","volume":"34","author":"M Rabinovitch","year":"1997","unstructured":"Rabinovitch, M. Pulmonary hypertension: updating a mysterious disease. Cardiovasc. Res. 34, 268\u2013272 (1997).","journal-title":"Cardiovasc. Res."},{"key":"BFnm764_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/(SICI)1099-0496(1999)27:18+<194::AID-PPUL63>3.0.CO;2-6","volume":"18","author":"LJ Rubin","year":"1999","unstructured":"Rubin, L.J. Cellular and molecular mechanisms responsible for the pathogenesis of primary pulmonary hypertension. Pediatr. Pulmonol. Suppl. 18, 194\u2013197 (1999).","journal-title":"Pediatr. Pulmonol. Suppl."},{"key":"BFnm764_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1056\/NEJM200108023450511","volume":"345","author":"J Loscalzo","year":"2001","unstructured":"Loscalzo, J. Genetic clues to the cause of primary pulmonary hypertension. N. Engl. J. Med. 345, 367\u2013371. (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnm764_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1089\/152702901750265288","volume":"2","author":"A Tucker","year":"2001","unstructured":"Tucker, A. & Rhodes, J. Role of vascular smooth muscle in the development of high altitude pulmonary hypertension: an interspecies evaluation. High Alt. Med. Biol. 2, 173\u2013189. (2001).","journal-title":"High Alt. Med. Biol."},{"key":"BFnm764_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/sj.bjp.0703570","volume":"131","author":"MR MacLean","year":"2000","unstructured":"MacLean, M.R., Herv\u00e9, P., Eddahibi, S. & Adnot, S. 5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. Br. J. Pharmacol. 131, 161\u2013168. (2000).","journal-title":"Br. J. Pharmacol."},{"key":"BFnm764_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/00000441-200104000-00009","volume":"321","author":"ED Michelakis","year":"2001","unstructured":"Michelakis, E.D. & Weir, E.K. Anorectic drugs and pulmonary hypertension from the bedside to the bench. Am. J. Med. Sci. 321, 292\u2013299. (2001).","journal-title":"Am. J. Med. Sci."},{"key":"BFnm764_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/thx.54.2.161","volume":"54","author":"P Egermayer","year":"1999","unstructured":"Egermayer, P., Town, G.I. & Peacock, A.J. Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension. Thorax 54, 161\u2013168. (1999).","journal-title":"Thorax"},{"key":"BFnm764_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","volume":"99","author":"P Herv\u00e9","year":"1995","unstructured":"Herv\u00e9, P. et al. Increased plasma serotonin in primary pulmonary hypertension. Am. J. Med. 99, 249\u2013254 (1995).","journal-title":"Am. J. Med."},{"key":"BFnm764_CR9","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1161\/01.ATV.20.10.2233","volume":"20","author":"A K\u00e9reveur","year":"2000","unstructured":"K\u00e9reveur, A. et al. High plasma serotonin levels in primary pulmonary hypertension: effect of long-term epoprostenol (Prostacyclin) therapy. Arterioscler. Thromb. Vasc. Biol. 20, 2233\u20132239 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnm764_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0014-5793(95)00828-W","volume":"370","author":"C Ullmer","year":"1995","unstructured":"Ullmer, C., Schmuck, K., Kalkman, H.O. & L\u00fcbbert, H. Expression of serotonin receptor mRNA in blood vessels. FEBS Lett. 370, 215\u2013221 (1995).","journal-title":"FEBS Lett."},{"key":"BFnm764_CR11","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1378\/chest.117.3.870","volume":"117","author":"S Rich","year":"2000","unstructured":"Rich, S., Rubin, L., Walker, A.M., Schneeweiss, S. & Abenhaim, L. Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension. Chest 117, 870\u2013874 (2000).","journal-title":"Chest"},{"key":"BFnm764_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1056\/NEJM199608293350901","volume":"335","author":"L Abenhaim","year":"1996","unstructured":"Abenhaim, L. et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N. Engl. J. Med. 335, 609\u2013616. (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFnm764_CR13","first-page":"75","volume":"57","author":"LW Fitzgerald","year":"2000","unstructured":"Fitzgerald, L.W. et al. Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine. Mol. Pharmacol. 57, 75\u201381 (2000).","journal-title":"Mol. Pharmacol."},{"key":"BFnm764_CR14","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1074\/jbc.271.6.3141","volume":"271","author":"J-M Launay","year":"1996","unstructured":"Launay, J.-M. et al. Ras involvement in signal transduction by the serotonin 5-HT2B receptor. J. Biol. Chem. 271, 3141\u20133147 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnm764_CR15","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1073\/pnas.050282397","volume":"97","author":"CG Nebigil","year":"2000","unstructured":"Nebigil, C.G., Launay, J.-M., Hickel, P., Tournois, C. & Maroteaux, L. 5-Hydroxytryptamine 2B receptor regulates cell-cycle progression: Cross talk with tyrosine kinase pathways. Proc. Natl. Acad. Sci. USA 97 2591\u20132596 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm764_CR16","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/j.1476-5381.1996.tb16700.x","volume":"117","author":"C Ullmer","year":"1996","unstructured":"Ullmer, C., Boddeke, H.G.W.M., Schmuck, K. & L\u00fcbbert, H. 5-HT2B receptor-mediated calcium release from ryanodine-sensitive intracellular stores in human pulmonary artery endothelial cells. Br. J. Pharmacol. 117, 1081\u20131088 (1996).","journal-title":"Br. J. Pharmacol."},{"key":"BFnm764_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/sj.bjp.0703341","volume":"130","author":"E Glusa","year":"2000","unstructured":"Glusa, E. & Pertz, H.H. Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT2B receptors. Br. J. Pharmacol. 130, 692\u2013698 (2000).","journal-title":"Br. J. Pharmacol."},{"key":"BFnm764_CR18","doi-asserted-by":"publisher","first-page":"9508","DOI":"10.1073\/pnas.97.17.9508","volume":"97","author":"CG Nebigil","year":"2000","unstructured":"Nebigil, C.G. et al. Serotonin 2B receptor is required for heart development. Proc. Natl. Acad. Sci. USA 97, 9508\u20139513 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm764_CR19","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1161\/01.CIR.103.24.2973","volume":"103","author":"CG Nebigil","year":"2001","unstructured":"Nebigil, C.G. et al. Ablation of serotonin 5-HT2B receptors in mice leads to abnormal cardiac structure and function. Circulation 103, 2973\u20132979 (2001).","journal-title":"Circulation"},{"key":"BFnm764_CR20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/sj.bjp.0702632","volume":"127","author":"DW Bonhaus","year":"1999","unstructured":"Bonhaus, D.W. et al. RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist. Br. J. Pharmacol. 127, 1075\u20131082 (1999).","journal-title":"Br. J. Pharmacol."},{"key":"BFnm764_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1165\/ajrcmb.16.4.9115746","volume":"16","author":"JK Belknap","year":"1997","unstructured":"Belknap, J.K., Orton, E.C., Ensley, B., Tucker, A. & Stenmark, K.R. Hypoxia increases bromodeoxyuridine labeling indices in bovine neonatal pulmonary arteries. Am. J. Respir. Cell. Mol. Biol. 16, 366\u2013371 (1997).","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"BFnm764_CR22","first-page":"L5","volume":"277","author":"M Rabinovitch","year":"1999","unstructured":"Rabinovitch, M. EVE and beyond, retro and prospective insights. Am. J. Physiol. 277, L5\u201312. (1999).","journal-title":"Am. J. Physiol."},{"key":"BFnm764_CR23","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1101\/gad.815400","volume":"14","author":"TH Vu","year":"2000","unstructured":"Vu, T.H. & Werb, Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 14, 2123\u20132133. (2000).","journal-title":"Genes Dev."},{"key":"BFnm764_CR24","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S0165-6147(99)01389-9","volume":"20","author":"MR MacLean","year":"1999","unstructured":"MacLean, M.R. Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action? Trends Pharmacol. Sci. 20, 490\u2013495 (1999).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnm764_CR25","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1164\/ajrccm.157.4.9704095","volume":"157","author":"S Eddahibi","year":"1998","unstructured":"Eddahibi, S., Raffestin, B., Launay, J.M., Sitbon, M. & Adnot, S. Effect of dexfenfluramine treatment in rats exposed to acute and chronic hypoxia. Am. J. Respir. Crit. Care Med. 157, 1111\u20131119 (1998).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnm764_CR26","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1172\/JCI8678","volume":"105","author":"S Eddahibi","year":"2000","unstructured":"Eddahibi, S. et al. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J. Clin. Invest. 105, 1555\u20131562 (2000).","journal-title":"J. Clin. Invest."},{"key":"BFnm764_CR27","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1172\/JCI2356","volume":"101","author":"W Steudel","year":"1998","unstructured":"Steudel, W. et al. Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J. Clin. Invest. 101, 2468\u20132477 (1998).","journal-title":"J. Clin. Invest."},{"key":"BFnm764_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1164\/ajrccm.164.2.2010150","volume":"164","author":"Y Hoshikawa","year":"2001","unstructured":"Hoshikawa, Y. et al. Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling. Am. J. Respir. Crit. Care Med. 164, 314\u2013318. (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnm764_CR29","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/hh2401.100426","volume":"89","author":"A Keegan","year":"2001","unstructured":"Keegan, A., Morecroft, I., Smillie, D., Hicks, M.N. & MacLean, M.R. Contribution of the 5-HT1B receptor to hypoxia-induced pulmonary hypertension. Converging evidence using 5-HT1B-receptor knockout mice and the 5-HT1B\/1D-receptor antagonist GR127935. Circ. Res. 89, 1231\u20131229 (2001).","journal-title":"Circ. Res."},{"key":"BFnm764_CR30","doi-asserted-by":"publisher","first-page":"119S","DOI":"10.1378\/chest.93.3_Supplement.119S","volume":"93","author":"M Rabinovitch","year":"1988","unstructured":"Rabinovitch, M. Problems of pulmonary hypertension in children with congenital cardiac defects. Chest 93, 119S\u2013126S. (1988).","journal-title":"Chest"},{"key":"BFnm764_CR31","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/01.CIR.99.5.605","volume":"99","author":"L Zhao","year":"1999","unstructured":"Zhao, L., Long, L., Morrell, N.W. & Wilkins, M.R. NPR-A-Deficient mice show increased susceptibility to hypoxia-induced pulmonary hypertension. Circulation 99, 605\u2013607 (1999).","journal-title":"Circulation"},{"key":"BFnm764_CR32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1476-5381.1975.tb07395.x","volume":"53","author":"W Buczko","year":"1975","unstructured":"Buczko, W., De Gaetano, G. & Garattini, S. Effect of fenfluramine on 5-hydroxytryptamine uptake and release by rat blood platelets. Br. J. Pharmacol. 53, 563\u2013359 (1975).","journal-title":"Br. J. Pharmacol."},{"key":"BFnm764_CR33","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","volume":"102","author":"RB Rothman","year":"2000","unstructured":"Rothman, R.B. et al. Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 102, 2836\u20132841. (2000).","journal-title":"Circulation"},{"key":"BFnm764_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1183\/09031936.02.00258702","volume":"20","author":"M Humbert","year":"2002","unstructured":"Humbert, M. et al. Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis. Eur. Respir. J. 20, 59\u201365 (2002).","journal-title":"Eur. Respir. J."},{"key":"BFnm764_CR35","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1164\/ajrccm.154.5.8912746","volume":"154","author":"R Naeije","year":"1996","unstructured":"Naeije, R., Maggiorini, M., Delcroix, M., Leeman, M. & Melot, C. Effects of chronic dexfenfluramine treatment on pulmonary hemodynamics in dogs. Am. J. Respir. Crit. Care Med. 154, 1347\u20131350. (1996).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnm764_CR36","first-page":"148","volume":"297","author":"S Eddahibi","year":"2001","unstructured":"Eddahibi, S. et al. Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats. J. Pharmacol. Exp. Ther. 297, 148\u2013154. (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnm764_CR37","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1172\/JCI200112805","volume":"108","author":"S Eddahibi","year":"2001","unstructured":"Eddahibi, S. et al. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J. Clin. Invest. 108, 1141\u20131150. (2001).","journal-title":"J. Clin. Invest."},{"key":"BFnm764_CR38","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1172\/JCI200114205","volume":"108","author":"M Rabinovitch","year":"2001","unstructured":"Rabinovitch, M. Linking a serotonin transporter polymorphism to vascular smooth muscle proliferation in patients with primary pulmonary hypertension. J. Clin. Invest. 108, 1109\u20131111. (2001).","journal-title":"J. Clin. Invest."},{"key":"BFnm764_CR39","first-page":"L795","volume":"272","author":"BL Fanburg","year":"1997","unstructured":"Fanburg, B.L. & Lee, S.L. A new role for an old molecule: serotonin as a mitogen. Am. J. Physiol. 272, L795\u2013806 (1997).","journal-title":"Am. J. Physiol."},{"key":"BFnm764_CR40","first-page":"L282","volume":"277","author":"SL Lee","year":"1999","unstructured":"Lee, S.L., Wang, W.W., Finlay, G.A. & Fanburg, B.L. Serotonin stimulates mitogen-activated protein kinase activity through the formation of superoxide anion. Am. J. Physiol. 277, L282\u2013291 (1999).","journal-title":"Am. J. Physiol."},{"key":"BFnm764_CR41","first-page":"L178","volume":"266","author":"BR Pitt","year":"1994","unstructured":"Pitt, B.R. et al. Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. Am. J. Physiol. 266, L178\u2013186 (1994).","journal-title":"Am. J. Physiol."},{"key":"BFnm764_CR42","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1023\/A:1006986824213","volume":"19","author":"C Sanchez","year":"1999","unstructured":"Sanchez, C. & Hyttel, J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell. Mol. Neurobiol. 19, 467\u2013489 (1999).","journal-title":"Cell. Mol. Neurobiol."},{"key":"BFnm764_CR43","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/76282","volume":"6","author":"KN Cowan","year":"2000","unstructured":"Cowan, K.N. et al. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nature Med. 6, 698\u2013702 (2000).","journal-title":"Nature Med."},{"key":"BFnm764_CR44","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1161\/hc3201.094152","volume":"104","author":"NW Morrell","year":"2001","unstructured":"Morrell, N.W. et al. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins. Circulation 104, 790\u2013795. (2001).","journal-title":"Circulation"},{"key":"BFnm764_CR45","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/01.RES.84.10.1223","volume":"84","author":"KN Cowan","year":"1999","unstructured":"Cowan, K.N., Jones, P.L. & Rabinovitch, M. Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. Circ. Res. 84, 1223\u20131233. (1999).","journal-title":"Circ. Res."},{"key":"BFnm764_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/00498258309052212","volume":"13","author":"KK Midha","year":"1983","unstructured":"Midha, K.K. et al. The identification of two new urinary metabolites of fenfluramine in man. Xenobiotica 13, 31\u201338. (1983).","journal-title":"Xenobiotica"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm764.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm764","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm764.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:32:36Z","timestamp":1684449156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,16]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["BFnm764"],"URL":"https:\/\/doi.org\/10.1038\/nm764","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9,16]]}}}